Elbit Systems Ltd. (NASDAQ: ESLT) is set to announce their third quarter 2017 results on Tuesday, November 14, 2017.
Q3/17 marked the 3rd consecutive quarter of increasing orders for Elbit, reaching record levels according to our estimates. The stock is up 4% since reporting a $300 million Command and Control Asia-Pacific order. This is off the back of a $240 million order from an African country for land and anti-ground solutions announced the day before. Years of overspending (as a percentage of revenue) in R&D is finally paying off for the company with increased spending on border security and land and air technology defense spending.
Quarterly Orders versus Sales
Forecast: The strong quarter for contract wins will continue to add to ESLT’s already record order backlog and will contribute positively to ESLT’s revenue for the years to come.
We expect ESLT to announce Q3/17 Y/Y revenue growth of 4% to $814M versus Q3/16 sales of $781M. We forecast Q3/17, we are forecasting adjusted EPS of $1.44, in-line with Q3/16 adjusted EPS of $1.46.
Our 2017 sales and adjusted EPS estimates of $3.45B and $6.27. This is materially higher than consensus of $3.45B and adjusted EPS of $5.74.
Q3/17, Q4/17, 2017 and 2018 Expectations
Source: Perspectec
Important Disclosures and Disclaimer
This publication is produced by Perspectec Inc. This publication and the contents hereof are intended for information purposes only, and may be subject to change without further notice. Any use, disclosure,
distribution, dissemination, copying, printing or reliance on this publication for any other purpose without our prior consent or approval is strictly prohibited. Neither Perspectec Inc. nor any of its respective parent, holding, subsidiaries or affiliates, nor any of its respective directors, officers, independent contractors, servants and employees, represent nor warrant the accuracy or completeness of the information contained herein or as to the existence of other facts which might be significant, and will not accept any responsibility or liability whatsoever for any use of or reliance upon this publication or any of the contents hereof.
No publications, nor any content hereof, constitute, or are to be construed as, an offer or solicitation of an offer to buy or sell any of the securities or investments.
This research report is not to be relied upon by any person in making any investment decision or otherwise advising with respect to, or dealing in, the securities mentioned, as it does not take into account the specific investment objectives, financial situation and particular needs of any person. Please refer to Persepctec Inc.’s terms of use disclosure and privacy policy https://perspectec.com/term_of_use
|
RATING |
CURRENT RATING |
PREVIOUS RATING |
|
BUY |
🗸 |
🗸 |
|
HOLD/NEUTRAL |
|
|
|
SELL |
|
|
For the purposes of complying with NYSE, NASDAQ and all Self-Regulatory Organizations, Perspectec Inc. has assigned the following rating system BUY, HOLD/NEUTRAL, SELL for the securities which are the views expressed by an analyst, Independent contractor, and or an employee of Perspectec Inc. The information and opinions in these reports were prepared by Perspectec Inc. or an analyst, independent contractor. Though the information herein is believed to be reliable and has been obtained from public sources believed to be reliable. Perspectec Inc. makes no representation as to its accuracy or completeness.
